LABD:ARCA-Direxion Daily S&P Biotech Bear 3X Shares (USD)

ETF | Trading--Inverse Equity | NYSE Arca

Last Closing

USD 5.5

Change

+0.43 (+8.48)%

Market Cap

USD 0.10B

Volume

0.03B

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, creates short positions by investing at least 80% of its assets in: swap agreements; futures contracts; options; reverse repurchase agreements; exchange-traded funds ("ETFs"); and other financial instruments that, in combination, provide inverse leveraged and unleveraged exposure to the S&P Biotechnology Select Industry Index. The index includes domestic companies from the biotechnology industry. The fund is non-diversified.

Inception Date: 28/05/2015

Primary Benchmark: S&P Biotechnology Select Industry TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.55%

Management Expense Ratio: 1.00 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-12 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Mer Price(Change) Market Cap
SH ProShares Short S&P500 0.89 %

-0.01 (-0.02%)

USD 0.95B
SOXS Direxion Daily Semiconductor B.. 0.97 %

+1.41 (+6.58%)

USD 0.66B
PSQ ProShares Short QQQ 0.95 %

+0.05 (+0.13%)

USD 0.61B
SPXU ProShares UltraPro Short S&P50.. 0.91 %

-0.01 (-0.05%)

USD 0.51B
SDOW ProShares UltraPro Short Dow30 0.95 %

-0.11 (-0.23%)

USD 0.29B
YANG Direxion Daily FTSE China Bear.. 1.02 %

+0.22 (+0.28%)

USD 0.17B
SPDN Direxion Daily S&P 500® Bear .. 0.45 %

N/A

USD 0.14B
RWM ProShares Short Russell2000 0.95 %

+0.17 (+0.96%)

USD 0.14B
DOG ProShares Short Dow30 0.95 %

-0.02 (-0.08%)

USD 0.13B
DUST Direxion Daily Gold Miners Ind.. 1.04 %

+1.86 (+2.92%)

USD 0.10B

ETFs Containing LABD

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Inverse Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -43.24% 25% F 4% F
Dividend Return 2.20% 26% F 40% F
Total Return -41.04% 25% F 4% F
Trailing 12 Months  
Capital Gain -73.43% 7% C- 1% F
Dividend Return 1.44% 11% F 19% F
Total Return -71.99% 7% C- 1% F
Trailing 5 Years  
Capital Gain -98.53% 11% F N/A F
Dividend Return 0.58% 15% F 2% F
Total Return -97.95% 13% F N/A F
Average Annual (5 Year Horizon)  
Capital Gain 177.83% 65% D 98% N/A
Dividend Return 178.67% 65% D 98% N/A
Total Return 0.84% 17% F 20% F
Risk Return Profile  
Volatility (Standard Deviation) 1,289.08% 36% F 2% F
Risk Adjusted Return 13.86% 44% F 32% F
Market Capitalization 0.10B 54% F 25% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.